Moriuchi Akie, Yamasaki Hironori, Shimamura Mika, Kita Atsushi, Kuwahara Hironaga, Fujishima Keiichiro, Satoh Tsuyoshi, Fukushima Keiko, Fukushima Tetsuya, Hayakawa Takao, Mizuguchi Hiroyuki, Nagayama Yuji, Abiru Norio, Kawasaki Eiji, Eguchi Katsumi
Department of Endocrinology and Metabolism, Unit of Translational Medicine, Graduate School of Biomedical Science, Nagasaki University, and Hospital of Medicine and Dentistry, Nagasaki, Japan.
Biochem Biophys Res Commun. 2007 May 18;356(4):1024-30. doi: 10.1016/j.bbrc.2007.03.084. Epub 2007 Mar 26.
Adiponectin, an adipose tissue-specific plasma protein, has been shown to ameliorate insulin resistance and inhibit the process of atherosclerosis. Recently, several reports have stated that angiotensin type 1 receptor blockers (ARBs), increase adiponectin plasma level, and ameliorate insulin resistance. Telmisartan, a subclass of ARBs, has been shown to be a partial agonist of the peroxisome proliferator-activated receptor (PPAR)-gamma, and to increase the plasma adiponectin level. However, the transcriptional regulation of the human adiponectin gene by telmisartan has not been determined yet. To elucidate the effect of telmisartan on adiponectin, the stimulatory regulation of human adiponectin gene by telmisartan was investigated in 3T3-L1 adipocytes, utilizing adenovirus-mediated luciferase reporter gene-transferring technique. This study indicates that telmisartan may stimulate adiponectin transcription independent of PPAR-gamma.
脂联素是一种脂肪组织特异性血浆蛋白,已被证明可改善胰岛素抵抗并抑制动脉粥样硬化进程。最近,有几份报告指出,1型血管紧张素受体阻滞剂(ARB)可提高血浆脂联素水平,并改善胰岛素抵抗。替米沙坦是ARB的一个亚类,已被证明是过氧化物酶体增殖物激活受体(PPAR)-γ的部分激动剂,并可提高血浆脂联素水平。然而,替米沙坦对人脂联素基因的转录调控尚未确定。为了阐明替米沙坦对脂联素的影响,利用腺病毒介导的荧光素酶报告基因转染技术,在3T3-L1脂肪细胞中研究了替米沙坦对人脂联素基因的刺激调控。这项研究表明,替米沙坦可能独立于PPAR-γ刺激脂联素转录。